Zai Lab Ltd. Files 8-K for Material Definitive Agreement

Ticker: ZLAB · Form: 8-K · Filed: Jul 9, 2024 · CIK: 1704292

Zai Lab Ltd 8-K Filing Summary
FieldDetail
CompanyZai Lab Ltd (ZLAB)
Form Type8-K
Filed DateJul 9, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.000006, $34.4 million
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Zai Lab just signed a big deal, filing an 8-K to let everyone know.

AI Summary

On July 9, 2024, Zai Lab Ltd. entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in the Cayman Islands with its principal executive offices in Shanghai, China, filed this 8-K report to disclose this event.

Why It Matters

This filing indicates Zai Lab Ltd. has entered into a significant financial agreement, which could impact its financial obligations and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements can introduce new financial obligations or strategic shifts that carry inherent risks.

Key Numbers

  • 001-38205 — SEC File Number (Identifies Zai Lab's filings with the SEC.)

Key Players & Entities

  • Zai Lab Ltd. (company) — Registrant
  • July 9, 2024 (date) — Date of earliest event reported
  • Cayman Islands (jurisdiction) — State or other jurisdiction of incorporation
  • Shanghai, China (location) — Principal executive offices

FAQ

What specific type of material definitive agreement did Zai Lab Ltd. enter into?

The filing indicates the entry into a material definitive agreement and a direct financial obligation, but the specific details of the agreement are not provided in this summary.

What is the nature of the direct financial obligation or off-balance sheet arrangement?

The filing states that Zai Lab Ltd. has created a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed here.

When was the report filed and what is the earliest event date?

The report was filed on July 9, 2024, and the earliest event reported is also July 9, 2024.

Where are Zai Lab Ltd.'s principal executive offices located?

Zai Lab Ltd.'s principal executive offices are located at 4560 Jinke Road, Bldg. 1, Fourth Floor, Pudong, Shanghai, China.

What is Zai Lab Ltd.'s standard industrial classification?

Zai Lab Ltd.'s Standard Industrial Classification is Pharmaceutical Preparations [2834].

Filing Stats: 863 words · 3 min read · ~3 pages · Grade level 11.1 · Accepted 2024-07-09 16:06:12

Key Financial Figures

  • $0.000006 — resenting 10 Ordinary Shares, par value $0.000006 per share ZLAB The Nasdaq Global Market
  • $34.4 million — of up to RMB250 million (approximately $34.4 million) from CMB to our wholly-owned subsidiar

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Zai Lab Limited (the "Company" or "we") identified an additional opportunity to access capital denominated in RMB through a debt facility with China Merchants Bank on favorable commercial terms to support our working capital needs in mainland China. As a result, on July 5, 2024, the Company issued a maximum-amount irrevocable letter of guarantee (the "Guarantee") to China Merchants Bank Co., Ltd., Shanghai Branch ("CMB") pursuant to which the Company will guarantee working capital loans of up to RMB250 million (approximately $34.4 million) from CMB to our wholly-owned subsidiary, Zai Lab (Shanghai) Co., Ltd. ("Zai Lab Shanghai"), and Zai Lab Shanghai entered into a Credit Agreement with CMB with respect to the RMB250 million facility. The credit facility will be available for one year, and key terms of the specific working capital loans, including the amount, term, and interest rate, will be included in the specific transaction documents. The Credit Agreement contains customary representations and warranties and affirmative and restrictive covenants, including a requirement to obtain prior written consent from CMB before engaging in certain transactions that could have an adverse impact on its debt repayment ability, such as mergers, acquisitions, spin-offs, equity transfers, and other material matters such as external investments and substantial increases in debt financings. The description of the Guarantee and Credit Agreement contained herein is qualified in its entirety by reference to the Guarantee, a copy of which is attached hereto as Exhibit 10.1, and the Credit Agreement, a copy of which is attached hereto as Exhibit 10.2, each of which is incorporated herein by reference. To date, Zai Lab Shanghai has not entered into any working capital loans under this debt facility. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant. The

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1+ Unofficial English Translation of Maximum-Amount Irrevocable Letter of Guarantee, dated as of July 5, 2024 , issued by Zai Lab Limited to China Merchants Bank Co., Ltd., Shanghai Branch 10.2+ Unofficial English Translation of Credit Agreement, dated as of July 5, 2024, by and between Zai Lab (Shanghai) Co., Ltd. and China Merchants Bank Co., Ltd., Shanghai Branch 104 The cover page of this report is formatted in Inline XBRL + Portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZAI LAB LIMITED By: /s/ F. Ty Edmondson Name: F. Ty Edmondson Title: Chief Legal Officer and Corporate Secretary Date: July 9, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.